Possible Cure For MS Turns Common Skin Cells Into Working Brain Cells
An anonymous reader writes "Scientists have discovered a way to convert ordinary skin cells into myelinating cells, or brain cells that have been destroyed in patients with multiple sclerosis, cerebral palsy and other myelin disorders. The research, published in the journal Nature Biotechnology, may now enable 'on demand' production of myelinating cells, which insulate and protect neurons to facilitate the delivery of brain impulses to the rest of the body."
Now that you've made myelin, how do you get it to stick to actual damaged neurons and/or brian cells. If you inject it in there, is it naturally just going to bind to damaged cells?
Q: How did Microsoft break Volkswagen's world record?
A: Volkswagen only made 22 million bugs!
Here's a first pass:
What do you get when you cure brain disease?
No more windows 8.
"Skkiiiinnnnnnn...."
The article wasn't clear on whether or not this could reverse the damage caused by MS or whether it would just prevent further damage. I know several people that suffer from this disease and it's utterly horrible. The worst case is my uncle who went from being in peak physical condition to requiring a cane or wheelchair to get around. He now stutters when he speaks, has trouble holding his head up, and can't keep his eyes still enough to even focus on words while trying to read. This disease slowly takes away all of your faculties and strips you of all autonomy and independence and a cure for it can't come fast enough.
Since ALS aka amaotrophic lateral sclerosis is caused by de-myelnizing of the nerve fibers - you could probably cure that too.
And since I have a slight risk this is good news.
Maybe I'm tired, or just having a slow day. The joke nearly went "whoosh" for me. Good one though!
The residents of Silicon Valley are more confused than usual after a billboard campaign by the National Multiple Sclerosis Society of America used this line in an ad slogan "MS, it's not a software company"... exploiting the fame of a certain company to draw attention to an altogether worthier cause.
Requests to comment on the campaign have been met by a surly silence by Microsoft, which doesn't relish the association of ideas but is painfully aware that it can't afford to appear insensitive over such an issue.
Seasoned information technology professionals will have no trouble telling the two MSs apart One is a debilitating and surprisingly widespread affliction that renders the sufferer barely able to perform the simplest task.
The other is a disease.
"Windows is like the faint smell of piss in a subway: it's there, and there's nothing you can do about it." - Charlie Br
Just a quick walk-through of the first section of the paper:
Cell-based therapies for myelin disorders, such as multiple sclerosis and leukodystrophies, require technologies to generate functional oligodendrocyte progenitor cells. Here we describe direct conversion of mouse embryonic and lung fibroblasts to induced oligodendrocyte progenitor cells (iOPCs) using sets of either eight or three defined transcription factors.
The Slashdot summary and 3rd party source says "skin cells", but the paper indicates the specific cell type used were "mouse embryonic fibroblasts (MEFs)"; specifically, they were MEFs isolated from a transgenic mouse lineage where a specific transactivator had already been engineered into their genome. This transactivator was designed to work together with the introduced Lentivirus vector (a retrovirus, member of the genus to which HIV belongs), carrying the Oligodendrocyte Progenitor Cell (OPC) transcription factors.
In a later section of the paper, they perform a similar process with "mouse lung fibroblasts" (MLFs), and also test several different combinations of transcription factors.
iOPCs exhibit a bipolar morphology and global gene expression profile consistent with bona fide OPCs. They can be expanded in vitro for at least five passages while retaining the ability to differentiate into multiprocessed oligodendrocytes.
Looks like a duck, quacks like a duck. Can be expanded into a flock while still retaining duck-ness.
When transplanted to hypomyelinated mice, iOPCs are capable of ensheathing host axons and generating compact myelin. Lineage conversion of somatic cells to expandable iOPCs provides a strategy to study the molecular control of oligodendrocyte lineage identity and may facilitate neurological disease modeling and autologous remyelinating therapies.
Induced OPC cells integrate into their normal niche, insulating neurons (at least at the cellular level). Didn't see much discussion of whether or not it altered the hypomyelinated ("shiver" mouse) phenotype.